Results 11 to 20 of about 120,820 (237)
Systemic Lupus Erythematosus [PDF]
BMJ, 1957 Lupus is a serious, potentially life-threatening disease. Its natural history is to culminate in a crescendo of autoimmunity and organ involvement. Difficulty arriving at the diagnosis may delay institution of therapy, which although helpful brings new problems. The fundamental understanding of this disease has made major strides. There is no consensus
openaire +6 more sources
Clinics, 2011 OBJECTIVE: The goal of the present study was to estimate the risk ratio of herpes zoster among systemic lupus erythematosus patients after disease onset compared with a cohort of patients without systemic lupus erythematosus over a three-year period ...
Hsin-Hua Chen +5 more
doaj +1 more source
Determinant Factors of Morbidity in Patients with Systemic Lupus Erythematosus
Acta Médica Portuguesa, 2017 Introduction: Severity in systemic lupus erythematosus may vary from mild to even fatal consequences. There are no biomarkers to predict the disease’s prognosis.
Margarida Jacinto +3 more
doaj +1 more source
Skin involvement in systemic lupus erythematosus: a review article [PDF]
Romanian Journal of Rheumatology, 2023 Cutaneous disease is one of the most frequent manifestations of systemic lupus erythematosus (SLE), being classified as LE-specific and LE-nonspecific.
Teodora Baciu +7 more
doaj +1 more source
Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects [PDF]
Anais Brasileiros de Dermatologia, 2014 Systemic Lupus Erythematosus is a chronic inflammatory disease with multifactorial etiology. Although clinical manifestations are varied, the skin is an important target-organ, which contributes to the inclusion of skin lesions in 4 out of the 17 new ...
Jucelio Pereira Moura Filho +6 more
doaj +1 more source
SAGE Open Medical Case Reports, 2020 Drug-induced lupus erythematosus has features distinct from primary systemic lupus erythematosus. It can occur with a wide variety of agents that result in the generation of anti-histone or other types of antibodies.
Umut Selamet +5 more
doaj +1 more source
DeckerMed Family Medicine, 2019 Systemic lupus erythematosus (SLE) is a chronic systemic autoimmune illness characterized by autoantibodies directed at nuclear antigens that cause clinical and laboratory abnormalities, such as rash, arthritis, leukopenia and thrombocytopenia, alopecia, fever, nephritis, and neurologic disease.
Kyriakos A. Kirou, Michael D. Lockshin
openaire +1 more source
The significance of M1/M2 macrophage-like monocytes in children with systemic lupus erythematosus
European Journal of Inflammation, 2019 Monocytes/macrophages are important in the development of systemic lupus erythematosus. To research M1 and M2 macrophage-like monocytes in the peripheral blood of children with systemic lupus erythematosus and explore the clinical significance, M1 and M2
Xiao-Ling Niu +6 more
doaj +1 more source
Clinics, 2015 OBJECTIVES: To determine the serum interleukin-17 (IL-17) levels in childhood-onset systemic lupus erythematosus patients and to evaluate the association between IL-17 and clinical manifestations, disease activity, laboratory findings and treatment ...
Karina de Oliveira Peliçari +7 more
doaj +1 more source
BMC Musculoskeletal Disorders, 2004 Background Systemic lupus erythematosus is an age- and gender-associated autoimmune disorder. Previous studies suggested that defects in the hypothalamic/pituitary axis contributed to systemic lupus erythematosus disease progression which could also ...
Malemud Charles J, Denko Charles W
doaj +1 more source